[1] |
Koh WJ,Abu-Rustum NR,Bean S,et al.Cervical Cancer,Version 3.2019,NCCN Clinical Practice Guidelines in Oncology[J].J Natl Compr Canc Netw,2019,17(1):64-84.
|
[2] |
Benard VB,Thomas CC,King J,et al.Vital signs:cervical cancer incidence,mortality,and screening-United States,2007-2012[J].MMWR Morb Mortal Wkly Rep,2014,63(44):1004-1009.
|
[3] |
Orbegoso C,Murali K,Banerjee S.The current status of immunotherapy for cervical cancer[J].Rep Pract Oncol Radiother,2018,23(6):580-588.
|
[4] |
Siegel RL,Miller KD,Jemal A.Cancer statistics,2019[J].CA Cancer J Clin,2019,69(1):7-34.
|
[5] |
Wong KY,Yu L,Chim CS.DNA methylation of tumor suppressor miRNA genes:a lesson from the miR-34 family[J].Epigenomics,2011,3(1):83-92.
|
[6] |
Baer C,Claus R,Plass C.Genome-wide epigenetic regulation of miRNAs in cancer[J].Cancer Res,2013,73(2):473-477.
|
[7] |
Kumar M,Lu Z,Takwi AA,et al.Negative regulation of the tumor suppressor p53 gene by microRNAs[J].Oncogene,2011,30(7):843-853.
|
[8] |
Bommer GT,Gerin I,Feng Y,et al.p53-mediated activation of miRNA34 candidate tumor-suppressor genes[J].Curr Biol,2007,17(15):1298-1307.
|
[9] |
Welch C,Chen Y,Stallings RL.MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells[J].Oncogene,2007,26(34):5017-5022.
|
[10] |
He L,He X,Lim LP,et al.A microRNA component of the p53 tumour suppressor network[J].Nature,2007,447(7148):1130-1134.
|
[11] |
He L,He X,Lowe SW,et al.microRNAs join the p53 network-another piece in the tumour-suppression puzzle[J].Nat Rev Cancer,2007,7(11):819-822.
|
[12] |
Hermeking H.p53 enters the microRNA world[J].Cancer Cell,2007,12(5):414-418.
|
[13] |
Luan S,Sun L,Huang F.MicroRNA-34a:a novel tumor suppressor in p53-mutant glioma cell line U251[J].Arch Med Res,2010,41(2):67-74.
|
[14] |
Yamakuchi M,Ferlito M,Lowenstein CJ.miR-34a repression of SIRT1 regulates apoptosis[J].Proc Natl Acad Sci U S A,2008,105(36):13421-13426.
|
[15] |
Yamakuchi M,Lowenstein CJ.MiR-34,SIRT1 and p53:the feedback loop[J].Cell Cycle,2009,8(5):712-715.
|
[16] |
娄文加,陈青,刘立,等.miR-34 家族——肿瘤抑制蛋白p53高度相关的microRNA[J].遗传,2010,32(5):423-430.
|
[22] |
Ji Q,Hao X,Meng Y,et al.Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres[J].BMC Cancer,2008,8:266.
|
[17] |
Kim NH,Kim HS,Kim NG,et al.p53 and microRNA-34 are suppressors of canonical Wnt signaling[J].Sci Signal,2011,4(197):a71.
|
[18] |
Liang W,Gao S,Liang L,et al.miRNA-34b is directly involved in the aging of macrophages[J].Aging Clin Exp Res,2017,29(4):599-607.
|
[19] |
Vogt M,Munding J,Grüner M,et al.Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal,pancreatic,mammary,ovarian,urothelial,and renal cell carcinomas and soft tissue sarcomas[J].Virchows Arch,2011,458(3):313-322.
|
[20] |
Christoffersen NR,Shalgi R,Frankel LB,et al.p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC[J].Cell Death Differ,2010,17(2):236-245.
|
[21] |
Shirmohamadi M,Eghbali E,Najjary S,et al.Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells[J].J Cell Physiol,2020,235(2):776-789.
|
[23] |
Ji Q,Hao X,Zhang M,et al.MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells[J].PLoS One,2009,4(8):e6816.
|
[24] |
Jiménez-Wences H,Peralta-Zaragoza O,Fernández-Tilapa G.Human papilloma virus,DNA methylation and microRNA expression in cervical cancer (Review)[J].Oncol Rep,2014,31(6):2467-2476.
|
[25] |
Ribeiro J,Sousa H.MicroRNAs as biomarkers of cervical cancer development:a literature review on miR-125b and miR-34a[J].Mol Biol Rep,2014,41(3):1525-1531.
|
[26] |
Li B,Hu Y,Ye F,et al.Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection[J].Int J Gynecol Cancer,2010,20(4):597-604.
|
[27] |
Wang F,Li B,Xie X.The roles and clinical significance of microRNAs in cervical cancer[J].Histol Histopathol,2016,31(2):131-139.
|
[28] |
Zhu Y,Han Y,Tian T,et al.MiR-21-5p,miR-34a,and human telomerase RNA component as surrogate markers for cervical cancer progression[J].Pathol Res Pract,2018,214(3):374-379.
|
[29] |
Geng D,Song X,Ning F,et al.MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin[J].Int J Gynecol Cancer,2015,25(4):707-713.
|
[30] |
Chandrasekaran KS,Sathyanarayanan A,Karunagaran D.Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation,migration and invasion of human cervical and colorectal cancer cells[J].Tumour Biol,2016,37(10):13 155-13 166.
|
[31] |
Yang M,Wang M,Li X,et al.Wnt signaling in cervical cancer?[J].J Cancer,2018,9(7):1277-1286.
|
[32] |
Li B,Guo X,Li N,et al.WNT1,a target of miR-34a,promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway[J].Cell Oncol (Dordr),2020,43(3):489-503.
|
[33] |
Zhang R,Su J,Xue SL,et al.HPV E6/p53 mediated downregulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer[J].Am J Cancer Res,2016,6(2):312-320.
|
[34] |
Li J,Yu L,Shen Z,et al.miR-34a and its novel target,NLRC5,are associated with HPV16 persistence[J].Infect Genet Evol,2016,44:293-299.
|
[35] |
Wang X,Xie Y,Wang J.Overexpression of MicroRNA-34a-5p Inhibits Proliferation and Promotes Apoptosis of Human Cervical Cancer Cells by Downregulation of Bcl-2[J].Oncol Res,2018,26(6):977-985.
|
[36] |
Chen AH,Qin YE,Tang WF,et al.MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer[J].Cancer Cell Int,2017,17:63.
|
[37] |
Shi C,Yang Y,Yu J,et al.The long noncoding RNA LINC00473,a target of microRNA 34a,promotes tumorigenesis by inhibiting ILF2 degradation in cervical cancer[J].Am J Cancer Res,2017,7(11):2157-2168.
|
[38] |
Jin J,Chen X,Chen J,et al.Long noncoding RNA MACC1-AS1 is a potential sponge of microRNA-34a in cervical squamous cell carcinoma and upregulates cyclin-dependent kinase 6[J].Oncol Lett,2020,19(3):2339-2345.
|
[39] |
Wang H,Zhang D,Chen Q,et al.Plasma expression of miRNA-21,-214,-34a,and-200a in patients with persistent HPV infection and cervical lesions[J].BMC Cancer,2019,19(1):986.
|
[40] |
Sommerová L,Fraňková H,Anton M,et al.Expression and Functional Characterization of miR-34c in Cervical Cancer[J].Klin Onkol,2018,31(Suppl 2):82-87.
|
[41] |
Cao Z,Zhang G,Xie C,et al.MiR-34b regulates cervical cancer cell proliferation and apoptosis[J].Artif Cells Nanomed Biotechnol,2019,47(1):2042-2047.
|